IDT Share Price Performance
AU$0
-0.07 (-100.00%)
Price AU$0
Share Pricen/a
IDT Australia Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
IDT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
IDT Australia Limited Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- -0.014
- 59.46%
- -32.26%
- 48.5%
About IDT
- Founded
- 1975
- Employees
- n/a
- CEO
- WebsiteView website
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers integrated services, including development, analytical testing, clinical packaging; and microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides formulation and manufacture of speciality orals (medicinal cannabis) and advanced therapies; psychedelics and medicinal cannabis; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, the company offers mRNA and antibody drug conjugates. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
